<!--
source: GPT-4o
abbr: SNRI
tags: antidepressants
-->

# Serotonin and norepinephrine reuptake inhibitors (SNRIs)

Serotonin and norepinephrine reuptake inhibitors (SNRIs) are a class of antidepressant medications used to treat depression, anxiety disorders, and certain chronic pain conditions. SNRIs work by inhibiting the reuptake of two key neurotransmitters, serotonin and norepinephrine, in the brain. By preventing the reabsorption of these neurotransmitters, SNRIs increase their levels in the synaptic cleft, enhancing mood and reducing symptoms of depression and anxiety.

Common SNRIs include venlafaxine (Effexor), duloxetine (Cymbalta), and desvenlafaxine (Pristiq). These medications are often prescribed when selective serotonin reuptake inhibitors (SSRIs) are not effective, as SNRIs provide a broader mechanism of action by targeting both serotonin and norepinephrine pathways. This dual action makes SNRIs particularly useful in treating conditions that involve both mood and physical pain, such as fibromyalgia and neuropathic pain.

While SNRIs are generally well-tolerated, they can cause side effects. Common side effects include nausea, dry mouth, dizziness, insomnia, and increased sweating. Some patients may also experience increased blood pressure, especially at higher doses. Like other antidepressants, SNRIs can take several weeks to achieve their full therapeutic effect and should be tapered off gradually under medical supervision to avoid withdrawal symptoms.

SNRIs offer a valuable option for patients who need more than what SSRIs can provide, addressing both emotional and physical aspects of their conditions. However, as with all antidepressants, they require careful management and regular follow-up with healthcare providers to optimize benefits and minimize risks.
